US1980A
(en)
|
|
1841-02-13 |
|
Mode oe |
DE116676C
(es)
|
|
|
|
|
US774011A
(en)
|
1904-05-25 |
1904-11-01 |
Felix Wedrick |
Governor for steam-engines.
|
DE1116676B
(de)
|
1955-03-14 |
1961-11-09 |
Thomae Gmbh Dr K |
Verfahren zur Herstellung von Pyrimido [5, 4-d] pyrimidinen
|
GB1051218A
(es)
|
1963-03-09 |
|
|
|
US3636039A
(en)
|
1970-02-24 |
1972-01-18 |
Hoffmann La Roche |
Substituted benzylimidazolidinones
|
GB1361441A
(en)
|
1970-05-13 |
1974-07-24 |
Sandoz Ltd |
Benzonaphthyridine derivatives
|
GB1338235A
(en)
|
1970-12-15 |
1973-11-21 |
May & Baker Ltd |
Azapurinones
|
DE2122529A1
(de)
|
1971-05-06 |
1972-12-14 |
Max Planck Gesellschaft zur Förde rung der Wissenschaften e V , 3400 Gottin gen |
Thiophosphatanaloge der Nucleosid di und tnphosphate sowie Verfahren zu ihrer Herstellung
|
BE794964A
(fr)
|
1972-02-04 |
1973-08-02 |
Bristol Myers Co |
Nouveaux agents hypotenseurs et procede pour les preparer
|
JPS5229318B2
(es)
|
1972-03-30 |
1977-08-01 |
|
|
GB1453703A
(en)
|
1972-12-28 |
1976-10-27 |
Science Union & Cie |
Substituted cyclopropylmethylamines processes for their preparation and pharmaceutical compositions containing them
|
DE2305339C3
(de)
|
1973-02-03 |
1980-05-08 |
Dr. Karl Thomae Gmbh, 7950 Biberach |
Imidazo [4,5-b] pyridine, ihre Herstellung und ihre Verwendung als Cardiötonica
|
AR205004A1
(es)
|
1973-10-30 |
1976-03-31 |
Ishikawa M |
Procedimiento para preparar derivados de 6,8-dialquil-7-alcoxi-carbonil-4-hidroximetil-1-ftalazona y la 7,8-lactona
|
US4016166A
(en)
|
1973-12-14 |
1977-04-05 |
Hisamitsu Pharmaceutical Co., Inc. |
1-Nitrophenylquinazoline-2,4(1H,3H)-diones
|
DE2402908C2
(de)
|
1974-01-22 |
1982-12-02 |
Fa. Johann A. Wülfing, 4040 Neuss |
7-(3-Oxobutyl)-1,3-di-(n-butyl)-xanthin und Verfahren zu seiner Herstellung
|
DE2413935A1
(de)
|
1974-03-20 |
1975-10-16 |
Schering Ag |
4-(polyalkoxy-phenyl)-2-pyrrolidone
|
US4049582A
(en)
|
1975-03-26 |
1977-09-20 |
Atlantic Richfield Company |
Method for producing a supported catalyst
|
US4072746A
(en)
|
1975-10-14 |
1978-02-07 |
Sterling Drug Inc. |
3-Amino-5-(pyridinyl)-2(1H)-pyridinones
|
IE46852B1
(en)
|
1977-06-10 |
1983-10-05 |
Otsuka Pharma Co Ltd |
Novel carbostyril derivatives
|
DE2727481A1
(de)
|
1977-06-18 |
1979-01-11 |
Basf Ag |
Dihydropyridazone und dihydropyridazone enthaltende therapeutische mittel
|
NL7807507A
(nl)
|
1977-07-25 |
1979-01-29 |
Hoffmann La Roche |
Tricyclische verbindingen.
|
CA1114379A
(en)
|
1977-11-03 |
1981-12-15 |
Pfizer Corporation |
Piperidino-phthalazines
|
DE2753244A1
(de)
|
1977-11-25 |
1979-06-07 |
Schering Ag |
Neue prostacyclinderivate und verfahren zu ihrer herstellung
|
JPS5527105A
(en)
|
1978-08-11 |
1980-02-27 |
Dai Ichi Seiyaku Co Ltd |
Imidazothienopyrimidinones compound
|
DE2837161A1
(de)
|
1978-08-25 |
1980-03-06 |
Thomae Gmbh Dr K |
Neue benzimidazole und deren verwendung
|
JPS5535019A
(en)
|
1978-09-01 |
1980-03-11 |
Otsuka Pharmaceut Co Ltd |
Carbostyryl derivative
|
DE2845220A1
(de)
|
1978-10-17 |
1980-04-30 |
Yoshitomi Pharmaceutical |
Pyridazinon-derivate, ihre salze mit saeuren, verfahren zu ihrer herstellung und ihre verwendung bei der behandlung von thrombosen und hypertonie
|
DE2845770A1
(de)
|
1978-10-19 |
1980-04-30 |
Schering Ag |
Neue prostacyclin-derivate und verfahren zu ihrer herstellung
|
DE2847693A1
(de)
|
1978-11-03 |
1980-05-22 |
Hoechst Ag |
Verfahren zur herstellung von pyrimido-(6,1-a)-isochinolin-2-onen
|
US4323570A
(en)
|
1978-11-15 |
1982-04-06 |
Beiersdorf Aktiengesellschaft |
Substituted aminopyrimidines
|
NZ193935A
(en)
|
1979-06-18 |
1985-05-31 |
Richardson Merrell Inc |
4-aroyl-imidazol-2-one derivatives;pharmaceutical compositions
|
GB2063249A
(en)
|
1979-10-09 |
1981-06-03 |
Mitsubishi Yuka Pharma |
4-Phenylphthalazine derivatives
|
NZ195564A
(en)
|
1979-11-26 |
1983-09-30 |
Sterling Drug Inc |
5-pyridinyl-2(1h)-pyridinones pharmaceutical compositions intermediate pyridine compounds
|
JPS5777676A
(en)
|
1980-10-31 |
1982-05-15 |
Otsuka Pharmaceut Co Ltd |
Carbostyril derivative
|
DE3048906A1
(de)
|
1980-12-19 |
1982-07-15 |
Schering Ag, 1000 Berlin Und 4619 Bergkamen |
Neue carbacycline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
|
US4405628A
(en)
|
1981-03-05 |
1983-09-20 |
Merrell Dow Pharmaceuticals Inc. |
4-Pyridylimidazolones and method of use
|
HU190412B
(en)
|
1981-09-17 |
1986-09-29 |
Warner-Lambert Co,Us |
Process for producing substituted 4,5-dihiydro-6-bracket-substituted-bracket closed-phenyl-3-bracket-2h-bracket closed-pyridazinones and 6-bracket-substituted-bracket closed-phenyl-3-bracket-2h-bracket closed-pyridazinones
|
JPS58124778A
(ja)
|
1982-01-20 |
1983-07-25 |
Toray Ind Inc |
5,6,7−トリノル−4,8−インタ−m−フエニレンPGI↓2誘導体
|
EP0096517A3
(en)
|
1982-06-05 |
1985-04-03 |
Smith Kline & French Laboratories Limited |
Aryl pyrazinones
|
DE3226550A1
(de)
|
1982-07-13 |
1984-01-19 |
Schering AG, 1000 Berlin und 4709 Bergkamen |
Neue carbacycline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
|
DE3241102A1
(de)
|
1982-11-06 |
1984-05-10 |
A. Nattermann & Cie GmbH, 5000 Köln |
Imidazolylalkylthienyl-tetrahydropyridazine und verfahren zu ihrer herstellung
|
US4490371A
(en)
|
1983-02-16 |
1984-12-25 |
Syntex (U.S.A.) Inc. |
N,N-Disubstituted-(2-oxo-1,2,3,5-tetrahydroimidazo-[2,1-B]quinazolinyl)oxyalkylamides
|
DE3306123A1
(de)
|
1983-02-18 |
1984-09-06 |
Schering AG, 1000 Berlin und 4709 Bergkamen |
Neue carbacycline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
|
GB8400863D0
(en)
|
1984-01-13 |
1984-02-15 |
Smith Kline French Lab |
Chemical compounds
|
GB8406906D0
(en)
|
1984-03-16 |
1984-04-18 |
Akzo Nv |
Benzo-thiazole and benzothiophene derivatives
|
DK159431C
(da)
|
1984-05-10 |
1991-03-18 |
Byk Gulden Lomberg Chem Fab |
6-phenyl-3(2h)-pyridazinoner, fremgangsmaade til fremstilling deraf, laegemidler indeholdende disse samt anvendelse af forbindelserne til fremstilling af laegemidler
|
GR851085B
(es)
|
1984-05-12 |
1985-11-25 |
Boehringer Mannheim Gmbh |
|
IL75122A
(en)
|
1984-05-14 |
1989-02-28 |
Lilly Co Eli |
3-methyl-5-(tetrahydro-6-oxopyridazin-3-yl)indoline derivatives,their preparation and use
|
DE3424685A1
(de)
|
1984-07-05 |
1986-02-06 |
Beiersdorf Ag, 2000 Hamburg |
Neue substituierte phenylpiperazinyl-propanole, verfahren zu ihrer herstellung und ihre verwendung sowie diese verbindungen enthaltende zubereitungen
|
JPS61218589A
(ja)
|
1985-03-26 |
1986-09-29 |
Eisai Co Ltd |
5―(6―イミダゾ〔1,2―a〕ピリジニル)ピリジン誘導体
|
ZW20586A1
(en)
|
1985-10-17 |
1988-05-25 |
Smith Kline French Lab |
Chemical compounds
|
AU591196B2
(en)
|
1985-11-15 |
1989-11-30 |
Nippon Kayaku Kabushiki Kaisha |
Novel forskolin derivatives
|
WO1987006576A1
(en)
|
1986-04-29 |
1987-11-05 |
Pfizer Inc. |
Calcium independent camp phosphodiesterase inhibitor antidepressant
|
DE3779374D1
(en)
|
1986-08-28 |
1992-07-02 |
Sandoz Ag |
Xanthinderivate.
|
US4871764A
(en)
|
1986-11-20 |
1989-10-03 |
Hoechst-Roussel Pharmaceuticals, Inc. |
12-Halogenated forskolin derivatives
|
NZ222843A
(en)
|
1986-12-22 |
1989-10-27 |
Ortho Pharma Corp |
Benzoxazinyl- and benzothiazinyl-tetrahydropyridazinones and intermediates, and medicaments
|
GB8630702D0
(en)
|
1986-12-23 |
1987-02-04 |
Wellcome Found |
Quinoline compound
|
CA1303037C
(en)
|
1987-02-02 |
1992-06-09 |
Smith Kline & French Laboratories Limited |
Purinone derivatives as bronchodilators vasodilators and anti-allergic agents
|
AU614965B2
(en)
|
1987-06-06 |
1991-09-19 |
Merck Patent Gesellschaft Mit Beschrankter Haftung |
Thiadiazinones
|
IL87149A
(en)
|
1987-07-20 |
1994-05-30 |
Merck & Co Inc |
6-Piperazinyl derivatives of purine and its 3- and 9-deaza isosteres, their preparation and pharmaceutical compositions containing them
|
US4922705A
(en)
|
1987-07-22 |
1990-05-08 |
Murata Kikai Kabushiki Kaisha |
Cleaning device for a drafting device in a spinning machine
|
DE3740838A1
(de)
|
1987-11-27 |
1989-06-08 |
Schering Ag |
Cyclodextrinclathrate von 5-cyano-prostacyclinderivaten und ihre verwendung als arzneimittel
|
JP2717687B2
(ja)
|
1988-02-13 |
1998-02-18 |
日本曹達株式会社 |
ピリダジノン誘導体及びその製造方法
|
US5142096A
(en)
|
1988-03-31 |
1992-08-25 |
Kyowa Hakko Kogyo Co., Ltd. |
2,4-dihydroxy-3,5,6-trimethylbenzoic acid compounds
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
GB8906792D0
(en)
|
1989-03-23 |
1989-05-10 |
Beecham Wuelfing Gmbh & Co Kg |
Treatment and compounds
|
WO1990012789A1
(de)
|
1989-04-17 |
1990-11-01 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
Neue arylpyridazine, ihre herstellung, verwendung und sie enthaltende arzneimittel
|
NZ234186A
(en)
|
1989-07-07 |
1991-10-25 |
Janssen Pharmaceutica Nv |
Imidazo quinazolin-one derivatives and pharmaceutical compositions
|
GB9413975D0
(en)
|
1994-07-11 |
1994-08-31 |
Fujisawa Pharmaceutical Co |
New heterobicyclic derivatives
|
US4943573A
(en)
|
1989-11-01 |
1990-07-24 |
Bristol-Myers Squibb Company |
Imidazo[4,5-b]quinolinyloxyalkanoic acid amides with enhanced water solubility
|
HU220962B1
(hu)
|
1989-11-13 |
2002-07-29 |
Pfizer Inc. |
Optikailag aktív 5-[3-(exo-biciklo[2.2.1]hept-2-il-oxi)-4-metoxi-fenil]-3,4,5,6-tetrahidropirimidin-2(1H)-on, enantiomere, valamint intermedierjeik
|
GB8929208D0
(en)
|
1989-12-27 |
1990-02-28 |
Almirall Lab |
New xanthine derivatives
|
US4963561A
(en)
|
1990-02-28 |
1990-10-16 |
Sterling Drug Inc. |
Imidazopyridines, their preparation and use
|
UA27031A1
(uk)
|
1990-04-25 |
2000-02-28 |
Ніссан Кемікал Індастріз Лтд |
Похідhі 3(2h)піридазиhоhу або їх фармацевтичhо прийhятhі солі, що мають протитромботичhу, позитивhу іhотропhу, судиhорозширювальhу дію й аhтиалергічhу активhість та фармацевтичhа композиція hа їх осhові
|
US5350864A
(en)
|
1990-05-03 |
1994-09-27 |
The United States Of America As Represented By The Department Of Health And Human Services |
Aminoalkylcarbamyl derivatives of forskolin as intermediates for the synthesis of useful forskolin derivatives
|
US5965695A
(en)
|
1990-05-15 |
1999-10-12 |
Chiron Corporation |
Modified peptide and peptide libraries with protease resistance, derivatives thereof and methods of producing and screening such
|
MY105344A
(en)
|
1990-05-16 |
1994-09-30 |
Byk Gulden Lomberg Chemische Fabrik |
New sulphonyl compounds
|
GB9013750D0
(en)
|
1990-06-20 |
1990-08-08 |
Pfizer Ltd |
Therapeutic agents
|
US5393788A
(en)
|
1990-07-10 |
1995-02-28 |
Smithkline Beecham Corporation |
Phenylalkyl oxamides
|
US5124455A
(en)
|
1990-08-08 |
1992-06-23 |
American Home Products Corporation |
Oxime-carbamates and oxime-carbonates as bronchodilators and anti-inflammatory agents
|
ATE168101T1
(de)
|
1990-10-16 |
1998-07-15 |
Byk Gulden Lomberg Chem Fab |
Arylpyridazinone
|
GB9027055D0
(en)
|
1990-12-13 |
1991-02-06 |
Sandoz Ltd |
Organic compounds
|
JPH04234389A
(ja)
|
1990-12-28 |
1992-08-24 |
Sapporo Breweries Ltd |
ナフチリジン誘導体及びそれを有効成分とする抗潰瘍剤
|
US5141931A
(en)
|
1991-01-03 |
1992-08-25 |
Sterling Winthrop Inc. |
5-Quinolinylpyridinones, cardiotonic compositions and methods
|
IE71647B1
(en)
|
1991-01-28 |
1997-02-26 |
Rhone Poulenc Rorer Ltd |
Benzamide derivatives
|
IE73235B1
(en)
|
1991-03-25 |
1997-05-21 |
Akzo Nv |
4-aryl-thiazole or imidazole derivatives
|
EP0510562A1
(de)
|
1991-04-26 |
1992-10-28 |
Byk Gulden Lomberg Chemische Fabrik GmbH |
Neue Pyridazine
|
US5191084A
(en)
|
1991-05-01 |
1993-03-02 |
American Home Products Corporation |
Phenyl pyrazolidinones as bronchodilators and anti-inflammatory agents
|
GB9116039D0
(en)
|
1991-07-25 |
1991-09-11 |
Ucb Sa |
Substituted cyclopropylamino-1,3,5-triazines
|
US5140102A
(en)
|
1991-09-23 |
1992-08-18 |
Monsanto Company |
Pentadecapeptide, guanylin, which stimulates intestinal guanylate cyclase
|
PT100905A
(pt)
|
1991-09-30 |
1994-02-28 |
Eisai Co Ltd |
Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
|
ES2105920B1
(es)
|
1991-10-09 |
1998-07-01 |
Syntex Inc |
Procedimiento para preparar compuestos de benzo-y piridopiridazinona y piridazinationa.
|
WO1993015045A1
(en)
|
1992-01-29 |
1993-08-05 |
Smithkline Beecham Corporation |
N-(3-phenylpropyl)oxamic acid, oxamate, and oxamide derivatives
|
WO1993015044A1
(en)
|
1992-01-29 |
1993-08-05 |
Smithkline Beecham Corporation |
N-benzyloxamic acid, oxamate, and oxamide derivatives and their use as tnf and pde iv inhibitors
|
GB9204808D0
(en)
|
1992-03-04 |
1992-04-15 |
Rhone Poulenc Rorer Ltd |
Novel compositions of matter
|
US5264437A
(en)
|
1992-03-20 |
1993-11-23 |
Syntex (U.S.A.) Inc. |
Optionally substituted pyrido[2,3-d]pyridine-2,4(1H,3H)-diones and pyrido[2,]pyrimidine-2(1H,3H)-ones
|
US5605923A
(en)
|
1992-04-02 |
1997-02-25 |
Smithkline Beecham Corporation |
Compounds useful for treating inflammatory diseases and inhibiting production of tumor necrosis factor
|
EP0633771A4
(en)
|
1992-04-02 |
1995-02-22 |
Smithkline Beecham Corporation |
Compounds.
|
AU677776B2
(en)
|
1992-04-02 |
1997-05-08 |
Smithkline Beecham Corporation |
Compounds useful for treating allergic and inflammatory diseases
|
AU3738293A
(en)
|
1992-04-02 |
1993-11-08 |
Smithkline Beecham Corporation |
Compounds useful for treating allergic and inflammatory diseases
|
AU670949B2
(en)
|
1992-06-15 |
1996-08-08 |
Celltech Limited |
Trisubstituted phenyl derivatives as selective phosphodiesterase IV inhibitors
|
JP2657760B2
(ja)
|
1992-07-15 |
1997-09-24 |
小野薬品工業株式会社 |
4−アミノキナゾリン誘導体およびそれを含有する医薬品
|
PL307265A1
(en)
|
1992-07-28 |
1995-05-15 |
Rhone Poulenc Rorer Ltd |
Compounds containing a phenyl group bonded with aryl or heteroaryl group through their bonding aliphatic group or that containing heteroatom
|
ATE178210T1
(de)
|
1992-09-14 |
1999-04-15 |
Forssmann Wolf Georg Prof Dr |
Neue verwendung von inhibitoren der phosphodiesterase iv
|
NZ257955A
(en)
|
1992-12-02 |
1996-05-28 |
Pfizer |
Catechol diethers pharmaceutical compositions
|
TW263495B
(es)
|
1992-12-23 |
1995-11-21 |
Celltech Ltd |
|
GB9304919D0
(en)
|
1993-03-10 |
1993-04-28 |
Celltech Ltd |
Chemical compounds
|
US5455252A
(en)
|
1993-03-31 |
1995-10-03 |
Syntex (U.S.A.) Inc. |
Optionally substituted 6,8-quinolines
|
US5459151A
(en)
|
1993-04-30 |
1995-10-17 |
American Home Products Corporation |
N-acyl substituted phenyl piperidines as bronchodilators and antiinflammatory agents
|
GB9309324D0
(en)
|
1993-05-06 |
1993-06-16 |
Bayer Ag |
Venzofuranyl-and-thiophenyl-alkanecarboxyclic acids derivatives
|
US5395490A
(en)
|
1993-05-14 |
1995-03-07 |
Intertec, Ltd. |
Method for treating materials by the application of electromagnetic energy at resonant absorption frequencies
|
GB9311282D0
(en)
|
1993-06-01 |
1993-07-21 |
Rhone Poulenc Rorer Ltd |
New compositions of matter
|
JPH0710875A
(ja)
|
1993-06-21 |
1995-01-13 |
Green Cross Corp:The |
選択的ホスホジエステラーゼiv阻害剤
|
GB9312853D0
(en)
|
1993-06-22 |
1993-08-04 |
Euro Celtique Sa |
Chemical compounds
|
EP0706513B1
(de)
|
1993-07-02 |
2002-05-15 |
Byk Gulden Lomberg Chemische Fabrik GmbH |
Fluoralkoxy substituierte benzamide und ihre verwendung als zyklisch-nukleotid phosphodiesterase-inhibitoren
|
CN1048015C
(zh)
|
1993-07-06 |
2000-01-05 |
美国辉瑞有限公司 |
双环四氢吡唑并吡啶类化合物
|
FR2707984B1
(fr)
|
1993-07-23 |
1995-09-01 |
Adir |
Nouvelles pipérazines substituées, leur procédé de préparation et les compositions les contenant.
|
ZA945609B
(en)
|
1993-07-28 |
1995-05-12 |
Rhone Poulenc Rorer Ltd |
[Di(ether or thioether)heteroaryl or fluoro substituted aryl] compounds
|
GB9315595D0
(en)
|
1993-07-28 |
1993-09-08 |
Res Inst Medicine Chem |
New compounds
|
WO1995003794A1
(en)
|
1993-07-30 |
1995-02-09 |
Smithkline Beecham Corporation |
3-cyano-3-(3,4-disubstituted)phenylcyclohexyl-1-carboxylates
|
WO1995005386A1
(en)
|
1993-08-19 |
1995-02-23 |
Smithkline Beecham Corporation |
Phenethylamine compounds
|
US5665754A
(en)
|
1993-09-20 |
1997-09-09 |
Glaxo Wellcome Inc. |
Substituted pyrrolidines
|
WO1995009624A1
(en)
|
1993-10-01 |
1995-04-13 |
Smithkline Beecham Corporation |
Compounds, compositions and treatment of allergies and inflammation
|
WO1995009836A1
(en)
|
1993-10-01 |
1995-04-13 |
Smithkline Beecham Corporation |
Cyanocyclohexane compounds, compositions, and uses thereof
|
WO1995009623A1
(en)
|
1993-10-01 |
1995-04-13 |
Smithkline Beecham Corporation |
Anti-allergic, anti-inflammatory compounds, compositions and uses
|
DE69429101T2
(de)
|
1993-10-01 |
2002-07-11 |
Smithkline Beecham Corp |
Verbindungen und zusammensetzungen zur behandlung von allergien und entzündungen
|
GB9322828D0
(en)
|
1993-11-05 |
1993-12-22 |
Sandoz Ltd |
Organic compounds
|
US5502072A
(en)
|
1993-11-26 |
1996-03-26 |
Pfizer Inc. |
Substituted oxindoles
|
ES2139754T3
(es)
|
1993-11-26 |
2000-02-16 |
Pfizer |
3-fenil-2-isoxazolinas como agentes antiinflamatorios.
|
WO1995014681A1
(en)
|
1993-11-26 |
1995-06-01 |
Pfizer Inc. |
Isoxazoline compounds as antiinflammatory agents
|
ATE260911T1
(de)
|
1993-12-22 |
2004-03-15 |
Celltech R&D Ltd |
Trisubstituierte phenyl-derivate, verfahren zu deren herstellung und deren verwendung als phosphodiesterase (typ iv) hemmstoffe
|
GB9326600D0
(en)
|
1993-12-22 |
1994-03-02 |
Celltech Ltd |
Chemical compounds
|
US5508300A
(en)
|
1994-01-14 |
1996-04-16 |
Pfizer Inc. |
Dihydro pyrazolopyrroles, compositions and use
|
JP2928079B2
(ja)
|
1994-02-14 |
1999-07-28 |
永信薬品工業股▲ふん▼有限公司 |
1−(置換ベンジル)−3−(置換アリール)縮合ピラゾール類、その製造法及びその用途
|
HUT74611A
(en)
|
1994-02-17 |
1997-01-28 |
American Home Prod |
Biphenyl derivatives with phosphodiesterase inhibitor activity and pharmaceutical compns. contg. them
|
CA2143143A1
(en)
|
1994-03-08 |
1995-09-09 |
Toshihiko Tanaka |
3-phenylpyrrolidine derivatives
|
GB9404706D0
(en)
|
1994-03-11 |
1994-04-27 |
Smithkline Beecham Corp |
Compounds
|
WO1995027692A1
(en)
|
1994-04-08 |
1995-10-19 |
Smithkline Beecham Corporation |
Subtituted biphenyl tnf inhibitors
|
AU699085B2
(en)
|
1994-04-21 |
1998-11-19 |
Schering Aktiengesellschaft |
PDE IV inhibitors for treating Multiple Sclerosis
|
GB9410877D0
(en)
|
1994-05-31 |
1994-07-20 |
Bayer Ag |
Heterocyclycarbonyl substituted benzoduranyl-and-thiophenyl-alkanecarboxyclic acid derivatives
|
HRP950288A2
(en)
|
1994-05-31 |
1997-08-31 |
Bayer Ag |
Oxalylamino-benzofuran- and benzothienyl-derivatives
|
EP0685475B1
(en)
|
1994-05-31 |
1999-01-13 |
Bayer Ag |
Amino-benzofuryl-and thienyl-derivatives
|
US5786354A
(en)
|
1994-06-21 |
1998-07-28 |
Celltech Therapeutics, Limited |
Tri-substituted phenyl derivatives and processes for their preparation
|
GB9412383D0
(en)
|
1994-06-21 |
1994-08-10 |
Celltech Ltd |
Chemical compound
|
DE69526790T2
(de)
|
1994-06-24 |
2003-03-06 |
Euro Celtique Sa |
Verbindungen zur hemmung von phosphodiesrerase iv
|
US5466697A
(en)
|
1994-07-13 |
1995-11-14 |
Syntex (U.S.A.) Inc. |
8-phenyl-1,6-naphthyridin-5-ones
|
KR100381584B1
(ko)
|
1994-07-22 |
2003-08-21 |
알타나 파마 아게 |
디히드로벤조푸란
|
AU699489B2
(en)
|
1994-10-12 |
1998-12-03 |
Euro-Celtique S.A. |
Novel benzoxazoles
|
FR2726558B1
(fr)
|
1994-11-03 |
1996-12-06 |
Adir |
Nouvelles 5-(aryloxymethyl) oxazolines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
US6169073B1
(en)
|
1995-02-16 |
2001-01-02 |
Bayer Corporation |
Peptides and peptidomimetics with structural similarity to human p53 that activate p53 function
|
US5831108A
(en)
|
1995-08-03 |
1998-11-03 |
California Institute Of Technology |
High metathesis activity ruthenium and osmium metal carbene complexes
|
US6331543B1
(en)
|
1996-11-01 |
2001-12-18 |
Nitromed, Inc. |
Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
|
FR2756560A1
(fr)
|
1996-12-04 |
1998-06-05 |
Adir |
Nouveaux derives de l'imidazoline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
JPH119282A
(ja)
|
1997-06-19 |
1999-01-19 |
Nippon Chem Res Kk |
メラトニン受容体発現細胞とその用途
|
AU9124998A
(en)
|
1997-08-29 |
1999-03-16 |
Inspire Pharmaceuticals |
Use of uridine 5'-diphosphate and analogs thereof for the treatment of lung iseases
|
US6329369B1
(en)
|
1997-12-04 |
2001-12-11 |
Allergan Sales, Inc. |
Methods of treating pain and other conditions
|
WO2000002878A1
(en)
|
1998-07-11 |
2000-01-20 |
University Of Bristol |
Compounds having activity at imidazoline receptors
|
US6624150B2
(en)
|
1999-02-26 |
2003-09-23 |
Inspire Pharmaceuticals, Inc. |
Method of treating gastrointestinal tract disease with purinergic receptor agonists
|
US6309633B1
(en)
|
1999-06-19 |
2001-10-30 |
Nobex Corporation |
Amphiphilic drug-oligomer conjugates with hydroyzable lipophile components and methods for making and using the same
|
MXPA02000684A
(es)
|
1999-07-19 |
2003-07-21 |
Univ North Carolina |
Conjugados de bloqueadores del canal de sodio y metodos de uso de los mismos.
|
DE19943635A1
(de)
|
1999-09-13 |
2001-03-15 |
Bayer Ag |
Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften
|
FR2801051B1
(fr)
|
1999-11-17 |
2001-12-14 |
Adir |
Nouveaux composes aminopyrroline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
GB9929216D0
(en)
|
1999-12-11 |
2000-02-02 |
Univ Bristol |
Isoquinoline and Quinoline Containing substances
|
EE200200355A
(et)
|
1999-12-22 |
2003-10-15 |
Pfizer Products Inc. |
EP4 retseptori selektiivsed agonistid osteoporoosi raviks
|
US20010056060A1
(en)
|
2000-02-07 |
2001-12-27 |
Cameron Kimberly O. |
Treatment of osteoporsis with EP2/EP4 receptor selective agonists
|
AU2001257146B2
(en)
|
2000-04-19 |
2006-11-30 |
Johns Hopkins University |
Methods for prevention and treatment of gastrointestinal disorders
|
EP1301792A2
(en)
|
2000-07-07 |
2003-04-16 |
University Of North Carolina At Chapel Hill |
Assay method and system for identification of p2y receptor agonists and antagonists
|
MXPA03004623A
(es)
|
2000-11-27 |
2003-09-05 |
Pfizer Prod Inc |
Agonistas selectivos del receptor ep4 en el tratamiento de la osteoporosis.
|
DE10063294A1
(de)
|
2000-12-19 |
2002-07-04 |
Aventis Pharma Gmbh |
Substituierte Heterocyclo-Norbornylamino-Derivate, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
|
GB0031295D0
(en)
|
2000-12-21 |
2001-01-31 |
Glaxo Group Ltd |
Naphthalene derivatives
|
GB0031302D0
(en)
|
2000-12-21 |
2001-01-31 |
Glaxo Group Ltd |
Napthalene derivatives
|
ES2622468T3
(es)
|
2001-03-29 |
2017-07-06 |
Synergy Pharmaceuticals, Inc. |
Agonistas del receptor de guanilato ciclasa para el tratamiento de inflamación tisular y carcinogénesis
|
WO2002079235A2
(en)
|
2001-03-30 |
2002-10-10 |
University Of Copenhagen |
Compositions and methods for modulating guanylyl cyclase signaling receptor (gc-c) activity and for treating meniere's disease
|
DK1456360T3
(en)
|
2001-04-19 |
2015-08-31 |
Scripps Research Inst |
Methods and Composition for Preparation of Orthogonal TRNA-Aminoacyl-TRNA Synthetase Pairs
|
EP1392729A2
(de)
|
2001-06-05 |
2004-03-03 |
Yalcin Cetin |
Verwendung eines peptids, welches guanylat cyclase c aktiviert, für die behandlung von atemwegserkrankungen über die luftwege, arzneimittel, inhalationsvorrichtung und diagnoseverfahren
|
US20030027853A1
(en)
|
2001-06-14 |
2003-02-06 |
Allergan Sales, Inc. |
3, 7or3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure
|
WO2003000056A1
(en)
|
2001-06-25 |
2003-01-03 |
Inspire Pharmaceuticals, Inc. |
Joint lubrication with p2y purinergic receptor agonists
|
DE10134481A1
(de)
|
2001-07-16 |
2003-01-30 |
Bayer Ag |
Substituierte 2-Thio-3,5-dicyano-4-phenyl-6-aminopyridine und ihre Verwendung
|
WO2003009872A1
(en)
|
2001-07-23 |
2003-02-06 |
Ono Pharmaceutical Co., Ltd. |
Remedies for diseases with bone mass loss having ep4 agonist as the active ingredient
|
US20040204590A1
(en)
|
2001-12-03 |
2004-10-14 |
Ogidigben Miller J. |
Ep4 receptor agonist, compositions and methods thereof
|
CA2466757A1
(en)
|
2001-12-03 |
2003-06-12 |
Merck & Co., Inc. |
Method for treating ocular hypertension
|
US20040121961A1
(en)
|
2002-02-04 |
2004-06-24 |
Jaime Masferrer |
Uroguanylin and cyclooxygenase-2 inhibitor combinations for inhibition of intestinal cancer
|
KR100592007B1
(ko)
|
2002-04-12 |
2006-06-21 |
화이자 인코포레이티드 |
Il-6 관련 질환 치료에서의 ep4 수용체 리간드의용도
|
US7414029B2
(en)
|
2002-05-23 |
2008-08-19 |
Theratechnologies, Inc. |
Antagonistic peptides of prostaglandin E2 receptor subtype EP4
|
JP4766875B2
(ja)
|
2002-06-06 |
2011-09-07 |
メルク フロスト カナダ リミテツド |
Ep4受容体作動薬、組成物及びその方法
|
WO2003103664A1
(en)
|
2002-06-06 |
2003-12-18 |
Merck Frosst Canada & Co. |
1,5-disubstituted imidazolidin-2-one derivatives for use as ep4 receptor agonists in the treatment of eye and bone diseases
|
PL372695A1
(en)
|
2002-06-19 |
2005-07-25 |
Solvay Pharmaceuticals Gmbh |
Medicament for the treatment of diseases requiring inhibition or a reduction in the activity of ph value-regulating bicarbonate transporter proteins
|
CA2495917A1
(en)
|
2002-08-28 |
2004-03-11 |
Merck Frosst Canada & Co. |
Oxazolidin-2-one and thiazolidin-2-one derivatives for use as ep4 receptor agonists in the treatment of glaucoma
|
JP2006505572A
(ja)
|
2002-10-25 |
2006-02-16 |
メルク フロスト カナダ アンド カンパニー |
Ep4受容体アゴニストとしての2−ピロリドン
|
US7053085B2
(en)
|
2003-03-26 |
2006-05-30 |
Merck & Co. Inc. |
EP4 receptor agonist, compositions and methods thereof
|
JP4582456B2
(ja)
|
2003-01-21 |
2010-11-17 |
小野薬品工業株式会社 |
8−アザプロスタグランジン誘導体およびその医薬用途
|
US7304036B2
(en)
|
2003-01-28 |
2007-12-04 |
Microbia, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
US20060281682A1
(en)
|
2003-01-28 |
2006-12-14 |
Currie Mark G |
Methods and compositions for the treatment of gastrointestinal disorders
|
US7371727B2
(en)
|
2003-01-28 |
2008-05-13 |
Microbia, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
ES2350123T3
(es)
|
2003-01-28 |
2011-01-18 |
Ironwood Pharmaceuticals, Inc. |
Composiciones para el tratamiento de trastornos gastrointestinales.
|
US7772188B2
(en)
|
2003-01-28 |
2010-08-10 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
WO2004071436A2
(en)
|
2003-02-10 |
2004-08-26 |
Thomas Jefferson University |
The use of gcc ligands
|
MXPA05008431A
(es)
|
2003-02-11 |
2005-10-19 |
Allergan Inc |
Derivados de acido 10,10-dialquil prostanoico como agentes para reducir la presion intraocular.
|
GB0306907D0
(en)
|
2003-03-26 |
2003-04-30 |
Angiogene Pharm Ltd |
Boireductively-activated prodrugs
|
US8134015B2
(en)
|
2003-03-27 |
2012-03-13 |
Kyowa Hakko Kirin Co., Ltd. |
Compound inhibiting in vivo phosphorous transport and medicine containing the same
|
US7326716B2
(en)
|
2003-06-06 |
2008-02-05 |
Allergan, Inc. |
Treatment of inflammatory bowel disease
|
US6747037B1
(en)
|
2003-06-06 |
2004-06-08 |
Allergan, Inc. |
Piperidinyl prostaglandin E analogs
|
US7494979B2
(en)
|
2003-06-13 |
2009-02-24 |
Ironwood Pharmaceuticals, Inc. |
Method for treating congestive heart failure and other disorders
|
US20070010450A1
(en)
|
2003-06-13 |
2007-01-11 |
Microbia, Inc., A Massachusetts Corporation |
Methods and compositions for the treatment of gastrointestinal disorders
|
US7015243B2
(en)
|
2003-08-28 |
2006-03-21 |
Allergan, Inc. |
Cyclohexyl prostaglandin analogs as EP4-receptor agonists
|
WO2005027931A1
(en)
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and an ep2 or ep4 selective agonist
|
WO2005060946A1
(en)
|
2003-12-17 |
2005-07-07 |
Pfizer Products Inc. |
Continuous combination therapy with selective prostaglandin ep4, receptor agonists and an estrogen for the treatment of conditions that present with low bone mass
|
US20050164987A1
(en)
|
2003-12-24 |
2005-07-28 |
Barberich Timothy J. |
Melatonin combination therapy for improving sleep quality
|
US20080025966A1
(en)
|
2004-01-30 |
2008-01-31 |
Currie Mark G |
Methods And Compositions For The Treatment Of Gastrointestinal disorders
|
US7169807B2
(en)
|
2004-04-09 |
2007-01-30 |
Allergan, Inc. |
10-Hydroxy-11-dihydroprostaglandin analogs as selective EP4 agonists
|
WO2005116010A1
(en)
|
2004-05-26 |
2005-12-08 |
Merck Frosst Canada Ltd. |
Ep4 receptor agonist, compositions and methods thereof
|
EP2722060A3
(en)
|
2004-06-25 |
2015-01-07 |
Thomas Jefferson University |
Guanylyl cyclase C ligands
|
US20110077292A1
(en)
|
2004-07-01 |
2011-03-31 |
Biotest Laboratories, Llc. |
Forskolin carbonates and uses thereof
|
US20060004090A1
(en)
|
2004-07-01 |
2006-01-05 |
Roberts William J |
Forskolin compositions and methods for administration
|
US20080234337A1
(en)
|
2004-08-10 |
2008-09-25 |
Ono Pharmaceutical Co., Ltd. |
Preventive and/or Remedy for Hyperkalemia Containing Ep4 Agonist
|
DE102004042607A1
(de)
|
2004-09-03 |
2006-03-09 |
Bayer Healthcare Ag |
Substituierte Phenylaminothiazole und ihre Verwendung
|
US20080132543A1
(en)
|
2004-10-26 |
2008-06-05 |
Wha Bin Im |
Therapeutic and Delivery Methods of Prostaglandin Ep4, Agonists
|
WO2006052630A1
(en)
|
2004-11-04 |
2006-05-18 |
Allergan, Inc. |
Therapeutic substituted piperidone compounds
|
US7101906B2
(en)
|
2004-11-16 |
2006-09-05 |
Allergan, Inc. |
2,3,4-substituted cyclopentanones as therapeutic agents
|
US7183324B2
(en)
|
2004-11-23 |
2007-02-27 |
Allergan, Inc. |
2,3,4-substituted cyclopentanones as therapeutic agents
|
CN101133037B
(zh)
|
2005-01-27 |
2012-05-09 |
旭化成制药株式会社 |
六元杂环化合物及其用途
|
US20090221649A1
(en)
|
2005-03-24 |
2009-09-03 |
Bayer Healthcare Ag |
Use of substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines for the treatment of reperfusion injury and reperfusion damage
|
WO2006137472A1
(ja)
|
2005-06-24 |
2006-12-28 |
Taisho Pharmaceutical Co., Ltd. |
プロスタグランジン誘導体
|
RU2008105481A
(ru)
*
|
2005-07-18 |
2009-08-27 |
Байер ХельсКер АГ (DE) |
Новое применение активаторов и стимуляторов растворимой гуанилатциклазыдля профилактики или лечения почечных расстройств
|
EP1912977A4
(en)
|
2005-08-03 |
2009-10-21 |
Merck Frosst Canada Ltd |
EP4 RECEPTOR AGONIST, COMPOSITIONS AND METHODS
|
EP1912957A4
(en)
|
2005-08-03 |
2009-05-13 |
Merck Frosst Canada Ltd |
EP4 AGONIST RECEIVER, COMPOSITIONS AND METHODS RESULTING THEREFROM
|
CA2619650A1
(en)
|
2005-08-19 |
2007-02-22 |
Microbia, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
US7893107B2
(en)
|
2005-11-30 |
2011-02-22 |
Allergan, Inc. |
Therapeutic methods using prostaglandin EP4 agonist components
|
GB0602900D0
(en)
|
2006-02-13 |
2006-03-22 |
Glaxo Group Ltd |
Novel Compounds
|
WO2007101158A2
(en)
|
2006-02-24 |
2007-09-07 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
US20090305993A1
(en)
*
|
2006-02-24 |
2009-12-10 |
Ironwood Pharmaceuticals, Inc. |
Methods and composition for the treatment of gastrointestinal disorders
|
DE102006009813A1
(de)
|
2006-03-01 |
2007-09-06 |
Bayer Healthcare Ag |
Verwendung von A2b/A1 Rezeptor Agonisten zur Modulation der Lipidspiegel
|
US7678808B2
(en)
|
2006-05-09 |
2010-03-16 |
Braincells, Inc. |
5 HT receptor mediated neurogenesis
|
JP2007329652A
(ja)
|
2006-06-07 |
2007-12-20 |
Nec Corp |
携帯通信端末及び携帯通信端末による印刷方法
|
US7705035B2
(en)
|
2006-06-12 |
2010-04-27 |
Merck Frosst Canada Ltd. |
Indoline amide derivatives as EP4 receptor ligands
|
GB0615105D0
(en)
|
2006-07-28 |
2006-09-06 |
Glaxo Group Ltd |
Novel compounds
|
GB0615111D0
(en)
|
2006-07-28 |
2006-09-06 |
Glaxo Group Ltd |
Novel compounds
|
US8969394B2
(en)
|
2006-08-11 |
2015-03-03 |
Merck Frosst Canada Ltd. |
Thiophenecarboxamide derivatives as EP4 receptor ligands
|
GB0620619D0
(en)
|
2006-10-17 |
2006-11-29 |
Glaxo Group Ltd |
Novel compounds
|
US8183286B2
(en)
|
2006-11-16 |
2012-05-22 |
Gemmus Pharma Inc. |
EP2 and EP4 agonists as agents for the treatment of influenza a viral infection
|
WO2008060632A2
(en)
|
2006-11-17 |
2008-05-22 |
Epix Delaware, Inc. |
Adenosine analogs and their use
|
GB0623203D0
(en)
|
2006-11-21 |
2007-01-03 |
Glaxo Group Ltd |
Novel compounds
|
JP5069752B2
(ja)
|
2006-12-15 |
2012-11-07 |
グラクソ グループ リミテッド |
Ep4受容体アゴニストとしてのベンズアミド誘導体
|
EP2129683A4
(en)
|
2007-02-26 |
2011-01-05 |
Ironwood Pharmaceuticals Inc |
METHODS AND COMPOSITIONS FOR TREATMENT OF HEART FAILURE AND OTHER DISORDERS
|
US7776896B2
(en)
|
2007-03-28 |
2010-08-17 |
Bayer Schering Pharma Aktiengesellschaft |
5-cyano-prostacyclin derivatives as agents for the treatment of influenza a viral infection
|
MX2009011898A
(es)
*
|
2007-05-04 |
2009-11-18 |
Ironwood Pharmaceuticals Inc |
Composiciones y metodos para tratar trastornos asociados con retencion de sal o fluido.
|
RU2009145280A
(ru)
|
2007-05-08 |
2011-06-20 |
Нэшнл Юниверсити Корпорейшн, Хамамацу Юниверсити Скул Оф Медсин (Jp) |
Активатор цитотоксических т-клеток, включающий агонист ep4
|
ES2393885T7
(es)
*
|
2007-06-04 |
2014-01-30 |
Synergy Pharmaceuticals Inc. |
Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
US20110171195A1
(en)
|
2007-06-15 |
2011-07-14 |
Duke University |
Methods and compositions for treating urinary tract infections using agents that mimic or elevate cyclic amp
|
JP2011523662A
(ja)
*
|
2008-06-04 |
2011-08-18 |
シナジー ファーマシューティカルズ インコーポレイテッド |
胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト
|
ES2522968T3
(es)
|
2008-06-04 |
2014-11-19 |
Synergy Pharmaceuticals Inc. |
Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
|
AU2009270833B2
(en)
|
2008-07-16 |
2015-02-19 |
Bausch Health Ireland Limited |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
|
HUE049023T2
(hu)
|
2008-08-15 |
2020-08-28 |
Ironwood Pharmaceuticals Inc |
Linaklotidot tartalmazó, szájon át történõ beadásra szolgáló készítmények
|
US9464275B2
(en)
|
2008-08-21 |
2016-10-11 |
The Board Of Trustees Of The Leland Stanford Junior University |
Ex vivo culture, proliferation and expansion of intestinal epithelium
|
EP2343292B1
(en)
|
2008-09-10 |
2014-08-06 |
Asahi Glass Company, Limited |
Novel prostaglandin i2 derivative
|
WO2010078449A2
(en)
*
|
2008-12-31 |
2010-07-08 |
Ardelyx, Inc. |
Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
|
EP2393917B1
(en)
|
2009-02-03 |
2016-04-06 |
Koninklijke Nederlandse Akademie van Wetenschappen |
Culture medium for epithelial stem cells and organoids comprising said stem cells.
|
GB201111244D0
(en)
|
2011-06-30 |
2011-08-17 |
Konink Nl Akademie Van Wetenschappen Knaw |
Culture media for stem cells
|
US9752124B2
(en)
|
2009-02-03 |
2017-09-05 |
Koninklijke Nederlandse Akademie Van Wetenschappen |
Culture medium for epithelial stem cells and organoids comprising the stem cells
|
EP2400975A4
(en)
|
2009-02-24 |
2012-11-28 |
Univ Jefferson |
Use of guanylyl cyclase c agonists to suppress appetite
|
JP5836262B2
(ja)
|
2009-03-19 |
2015-12-24 |
フェイト セラピューティクス, インコーポレイテッド |
サイクリックampエンハンサーおよび/またはepリガンドを含む組成物、ならびにこれを調製および使用する方法
|
CN102482326A
(zh)
|
2009-04-10 |
2012-05-30 |
科登制药科罗拉多公司 |
分离治疗用肽的方法
|
MX2012005368A
(es)
|
2009-11-09 |
2012-06-13 |
Ironwood Pharmaceuticals Inc |
Tratamientos para transtornos gastrointestinales.
|
UA108636C2
(xx)
|
2010-02-17 |
2015-05-25 |
|
Пептид
|
WO2011140441A2
(en)
|
2010-05-06 |
2011-11-10 |
Children's Hospital Medical Center |
Methods and systems for converting precursor cells into intestinal tissues through directed differentiation
|
WO2011156453A2
(en)
*
|
2010-06-09 |
2011-12-15 |
Combimab, Inc. |
Therapeutic peptides
|
WO2012054110A2
(en)
*
|
2010-07-07 |
2012-04-26 |
Ardelyx, Inc. |
Compounds and methods for inhibiting phosphate transport
|
WO2012006475A1
(en)
*
|
2010-07-07 |
2012-01-12 |
Ardelyx, Inc. |
Compounds and methods for inhibiting phosphate transport
|
JP5827328B2
(ja)
*
|
2010-07-07 |
2015-12-02 |
アーデリクス,インコーポレーテッド |
リン酸輸送を阻害する化合物及び方法
|
DK2776055T3
(en)
*
|
2011-08-17 |
2017-03-06 |
Ironwood Pharmaceuticals Inc |
TREATMENTS FOR GASTROINTESTINAL DISORDERS
|
CA2861804C
(en)
|
2011-12-27 |
2021-10-26 |
Ironwood Pharmaceuticals, Inc. |
2-benzyl,3(pyrimidin-2-yl)substituted pyrazoles useful as sgc stimulators
|
SI2983667T1
(sl)
*
|
2013-04-12 |
2019-09-30 |
Ardelyx, Inc. |
Spojine za vezavo NHE3 in metode za zaviranje transporta fosfata
|
JP2014234389A
(ja)
|
2013-05-30 |
2014-12-15 |
住友ゴム工業株式会社 |
乗用車用タイヤのトレッド用ゴム組成物およびそれを用いた乗用車用タイヤ
|
JP6694385B2
(ja)
*
|
2013-08-09 |
2020-05-13 |
アーデリクス,インコーポレーテッド |
リン酸塩輸送阻害のための化合物及び方法
|
JP7015745B2
(ja)
|
2018-07-19 |
2022-02-03 |
株式会社ジェイエスエス |
水中用運動具
|